Vita Coco CFO sells 2,000 shares under 10b5-1 plan

Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported an open‑market sale of 2,000 shares of common stock on March 19, 2026 at an average price of $55.45 per share.

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported an open‑market sale of 2,000 shares of common stock on March 19, 2026 at an average price of $55.45 per share. The sale was executed under a Rule 10b5‑1 trading plan, indicating it was pre‑scheduled rather than a discretionary trade.

After this transaction, Baker directly holds 25,951 common shares. He also holds several non‑qualified stock options to acquire additional Vita Coco common shares, with exercise prices ranging from $16.91 to $33.36 and expiration dates between 2033 and 2035.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares

Net Sell 6 txns

Insider BAKER COREY

Role Chief Financial Officer

Sold 2,000 shs ($111K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$55.45	$111K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 25,951 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 56,197 contracts (Direct)

Footnotes (5)

1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. F2. The stock option vests in four equal annual installments beginning on March 10, 2024.
3. F3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
4. F4. The stock option vests in four equal annual installments beginning on March 4, 2025.
5. F5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vita Coco (COCO) CFO Corey Baker report in this Form 4?

Corey Baker reported selling 2,000 Vita Coco common shares in an open‑market transaction at $55.45 per share. The filing also confirms he continues to hold 25,951 common shares plus multiple non‑qualified stock options for additional shares.

At what price did Vita Coco CFO Corey Baker sell his COCO shares?

Corey Baker sold 2,000 Vita Coco common shares at an average price of $55.45 per share. This was an open‑market sale, and the filing notes the transaction occurred on March 19, 2026 under a pre‑arranged Rule 10b5‑1 plan.

How many Vita Coco (COCO) shares does the CFO hold after this sale?

After the sale, Corey Baker directly holds 25,951 Vita Coco common shares. In addition to this ownership, he has several non‑qualified stock options outstanding that are exercisable into common shares at preset prices over future years.

Was the Vita Coco CFO’s COCO share sale made under a Rule 10b5-1 plan?

Yes. A footnote states the common stock sales were effected pursuant to a Rule 10b5‑1 trading plan. Such plans are pre‑arranged trading programs that schedule transactions in advance, reducing the significance of trade timing as an information signal.

What stock options does Vita Coco (COCO) CFO Corey Baker still hold?

Corey Baker holds several non‑qualified stock options to buy Vita Coco common stock, with exercise prices between $16.91 and $33.36. These options cover specified share amounts and have expiration dates from 2033 through 2035, according to the derivative holdings disclosure.

Does this Vita Coco Form 4 show any option exercises by the CFO?

No option exercises are reported; the filing only shows an open‑market sale of 2,000 common shares. The derivative section lists existing non‑qualified stock options as holdings, with their exercise prices and expiration dates, but no exercise transactions on March 19, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 05:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		S(1)		2,000	D	$55.45	25,951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$16.91							(2)	03/10/2033	Common Stock	9,205		9,205	D
Non-Qualified Stock Option (Right to Buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, attorney-in-fact for Corey Baker	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)